“BEST UNDER A BILLION” AWARD BY FORBES ASIA
In June 2015, we were honoured to be selected by Forbes
Asia as one of the “Best Under a Billion” companies. The list
honours 200 leading public companies in the Asia-Pacific
region with an annual revenue between US$5 million
and US$1 billion and positive net income. The Group was
handpicked from a universe of 17,000 companies where
candidates were screened based on sales and earnings
growth in the past 12 months and three-year periods, and
five-year return on equity. Winning this accolade attests to
the success and growth of the Group, which has grown at
a 28.8% revenue CAGR for the past two years.
1 Health Statistics Year Book, Deloitte Analysis
APPRECIATION
Ours was certainly a journey that was firmly supported by
dedicated staff, a committed management team and the
Board. I would like this opportunity to express appreciation
to my fellow board members, our business associates and
shareholders for their continued support. I would also
like to thank our management team and all staff for their
dedication to the Group.
Finally, my heartfelt gratitude goes to parents who have
trusted us and made the decision to store their babies’
precious cord blood and cord lining with us. We will
continue to uphold their trust in us.
DR. HO CHOON HOU
Chairman and Non-Executive Director
10
CORDLIFE GROUP LIMITED
| ANNUAL REPORT 2015
CHAIRMAN’S
MESSAGE
